期刊
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
卷 2020, 期 34, 页码 3242-3248出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejic.202000545
关键词
Antitumor agents; Ruthenium; Medicinal inorganic chemistry; Photodynamic therapy
资金
- ERC Consolidator Grant PhotoMedMet [681679]
- program Investissements d'Avenir [ANR-10-IDEX-0001-02 PSL]
- National Science Foundation of China [21525105, 21778079]
- 973 Program [2015CB856301]
- European Research Council (ERC) [681679] Funding Source: European Research Council (ERC)
The therapy of cancer remains a major challenge for modern medicine. Complementary to classical treatments, the use of photodynamic therapy (PDT) has received increasing attention over the last decades. Among the classes of PDT photosensitizers (PSs) investigated, Ru(II)polypyridine complexes are currently considered as a valuable option. To improve the water solubility of these lipophilic compounds and generate a drug delivery system, these complexes can be encapsulated with polymers. Herein, the physical encapsulation of the photoactive [Ru((E,E')-4,4'-bis[p-methoxystyryl]-2,2'-bipyridine)(3)][PF6](2)complex with the polymer Pluronic F-127/Poloxamer-407 is presented. The resulting spherical particles were found to have a toxic effect in the micromolar range in human cervical carcinoma cells upon light irradiation (500 nm).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据